Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
نویسندگان
چکیده
منابع مشابه
Targeting the tumor-stromal-immune cell axis
Cancer associated fibroblasts (CAFs) in the tumor microenvironment (TME) play a critical role in tumor progression. We and others have demonstrated that stromal fibroblasts can transform adjacent epithelial cancer cells in vivo. Cancer cells and stromal cells interact through physical contact, mediated by soluble factors, insoluble extracellular matrices (ECMs) or extracellular vesicles (EVs) i...
متن کاملTargeting tumor-necrosis factor receptor pathways for tumor immunotherapy
With the success of ipilimumab and promise of programmed death-1 pathway-targeted agents, the field of tumor immunotherapy is expanding rapidly. Newer targets for clinical development include select members of the tumor necrosis factor receptor (TNFR) family. Agonist antibodies to these co-stimulatory molecules target both T and B cells, modulating T-cell activation and enhancing immune respons...
متن کاملO 25: Immunotherapy for Brain Tumor
In 1890, Coley observed that cancer patients who developed infections had smaller tumors. From this, he developed Coley’s toxin and treated tumors with injections of infectious materials. In 1960s, Mahaley used monoclonal antibodies to treat central nervous system(CNS) tumors, that research and clinical investigations in brain tumor immunotherapy became a serious undertaking. ...
متن کاملTargeting the right regulatory T-cell population for tumor immunotherapy
Regulatory T cells (Tregs) that suppress tumor-specific T cell-mediated immune responses are the subject of an intense wave of investigation. We recently reported that a subset of Tregs, namely effector/memory CD25(low) cells, are responsible for suppressing high avidity tumor-specific T cells in mouse mammary tumors. Here, we discuss additional findings that clarify this mechanism of Treg-medi...
متن کاملCancer immunotherapy targeting Wilms' tumor gene WT1 product.
The Wilms' tumor gene WT1 is expressed at high levels in leukemic blast cells in most acute myeloid and lymphoblastic leukemias. In myelodysplastic syndrome, WT1 mRNA expression levels increase along with disease progression; thus, WT1 mRNA is a tumor marker for leukemic blast cells. WT mRNA is also expressed at high levels in various types of solid cancers, including cancers of the lung, breas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Medicinal Chemistry
سال: 2019
ISSN: 0929-8673
DOI: 10.2174/0929867324666170830111531